United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift Medical’s Patent

MolecuLight Victorious in its Efforts to Prove Swift Medical Did Not Merit a Patent TORONTO and ALEXANDRIA, VA, Nov. 21, 2023 /PRNewswire/ — MolecuLight® Inc., the leader in real-time detection of elevated bacterial loads in wounds through point-of-care fluorescence imaging, is pleased…

Click here to view original post

Advertise With Biotech Networks